Polycystic Ovary Syndrome (PCOS)
PCOS is fundamentally a metabolic condition driven by systemic insulin resistance, which forces the ovaries to overproduce androgens (testosterone). The clinical goal is to restore insulin sensitivity and normalize ovulatory function.
The Core PCOS Protocol
First-line defense for restoring ovarian signaling.
Myo-Inositol Complex (40:1)
40:1 Ratio. The 40:1 Myo-to-D-chiro ratio is non-negotiable for follicular health.
The 40:1 ratio mimics physiological follicular fluid levels. It improves insulin sensitivity and reduces LH/FSH ratio imbalances.
Read Full Clinical ReviewThe 40:1 Clinical Study
Inositol acts as a "second messenger" for insulin. In PCOS, the cell's insulin receptor is essentially "deaf". Clinical studies demonstrate that the exact physiological ratio of 40:1 (Myo-Inositol to D-Chiro Inositol) repairs this signaling significantly faster than isolated Myo-inositol. It allows glucose to enter the cell, instantly signaling the ovaries to halt androgen overproduction and resume regular ovulation.
Secondary Metabolic Support
Berberine Phytosome
Phytosomal Delivery (Berbevis). Standard Berberine HCl requires high doses (1500mg) due to P-glycoprotein efflux. We recommend Phytosomal forms to bypass this, as per recent pharmacokinetic trials (2025).
- Maximum glucose stabilization without stomach cramps
- Significant reduction in late-night sugar cravings
- Improved lipid profile and triglyceride clearance
For severe PCOS cases with marked weight gain or pre-diabetes, Inositol alone may not be enough. Stacking it with Berberine Phytosome activates AMPK (the metabolic master switch), clearing systemic glucose while avoiding the gastrointestinal distress of standard Berberine.